INTRODUCTION
Baculoviruses are a group of pathogens that specifically infect invertebrates, primarily lepidopterans. Among them, Autographa californica multiple nucleopolyhedrovirus (AcMNPV) is one of the most frequently used baculoviruses for foreign gene expression because of its numerous advantages. First, baculovirus is safe for human application because of its inability to either replicate or integrate its genome into the chromosomes of vertebrate cells. 1, 2 Therefore, it can be produced with high titers in biosafety level 1 facilities by infecting its natural insect hosts. 3 Second, baculovirus has a large genome ($134 kb) and, hence, possesses a cloning capacity as large as 38 kb. 4 Third, it is better than other protein expression systems, such as E. coli and yeast, in terms of its high levels of gene expression and proper post-translational modifications of the engineered protein. 5 These characteristics make baculovirus a desirable system for protein production.
Baculovirus has been used as a gene delivery vector for a wide variety of applications, including multigene delivery for in vivo creation of virus-like particles, 6 in cancer gene therapy 7 and regenerative medicine, and as vaccine vectors. 8, 9 In the last decade, baculovirus has been widely used as a safe and convenient tool for foreign gene delivery into mammalian cells. 10 Despite its potential as a safe and useful tool, the levels of transgene expression mediated by baculovirus vectors are significantly restricted by host immune systems in mammalian cells.
Upon virus infection, host cells respond with a strong antiviral immune response. Pathogenic viruses can counteract certain host cell defenses through host-pathogen co-evolution, so a complete picture of host responses is not yet clear. However, baculovirus is not an established pathogen against mammalian cells, and thus it provides a unique opportunity for us to study the immune response to a DNA virus that is not adapted to infecting mammalian cells. Baculovirus has been shown to stimulate some innate immune responses in mammalian cells, including human mesenchymal stem cells (MSCs) 11, 12 and mouse embryonic fibroblasts (MEFs). 13 A global analysis of host immune responses against baculovirus would also provide a comprehensive view of host defenses against a "nonadaptive" viral agent.
Induction of host immune responses by pathogens is mediated by activation of pattern recognition receptors (PRRs). There are four major groups of mammalian PRRs: Toll-like receptors (TLRs), retinoic acid-inducible protein I (RIG-I)-like receptors (RLRs), nucleotide oligomerization domain (NOD)-like receptors (NLRs), and the DNA-sensing receptor ZBP1. 14, 15 All of these receptors are responsible for recognition of viral nucleic acids and viral factors in the cytosol. In human MSCs, TLR3, a receptor that generally recognizes double-stranded RNA, has been shown to be upregulated by baculovirus transduction, triggering the production of interleukin-6 (IL-6) and IL-8, but not b-IFN or other inflammatory cytokines. 16 Transduction of baculovirus in chondrocytes elicited IFN-a/b expression, which repressed transgene expression in a dose-dependent manner. 17 In MEFs, baculovirus has been shown to induce the secretion of inflammatory cytokines and type I IFNs through both TLR-dependent and -independent pathways. 13 Furthermore, transgene expression of recombinant baculovirus was enhanced in MEFs deficient for innate immune signaling pathway genes, including STING, TBK1, IRF3, and IPS-1. 18 These results show that the innate immune responses induced by baculovirus transduction attenuate transgene expression in mammalian cells. Thus, it is of great interest to decipher the relationship between baculoviral transgene expression and antiviral mechanisms in mammalian cells. This information will be invaluable for developing baculovirus gene therapies or when using baculovirus as a mammalian gene transfer vector.
Human lung cancer A549 cells have been commonly used in influenza virus vaccine-related studies, including for viruses H7N9 19 and H1N1, 20 and to discern the molecular mechanisms involved in the pathogenicity of avian influenza virus (H5N1 or H9N2). [20] [21] [22] In cell-based assays, a high level of transgene expression by recombinant baculovirus is necessary to attain detection sensitivity. Although baculovirus can efficiently transduce most mammalian cell types without any replication, transgenes are not very efficiently expressed in some cells, including A549. 10 The reason for the low expression may be host resistance mediated by innate immune responses induced by baculovirus transduction. 18 In this study, we transduced A549 cells with baculovirus and performed an intensive and iterative cell screen with a short hairpin RNA (shRNA) library highly enriched for human antiviral response pathways, including TLRs, RLRs, NLRs, and cytosolic DNA-sensing pathways. Of the 176 genes assayed, knockdown of 102 genes resulted in elevated gene expression driven by the cytomegalovirus immediate early enhancer (CMV) promoter, whereas downregulation of gene expression by the same promoter occurred in 31 genes. Among them, RIP1 knockdown enhanced baculoviral transgene expression 10-fold and was the only one of these 102 genes for which cell viability was not significantly affected upon knockdown of the target genes. We found that increased luciferase activity in RIP1 knockdown A549 cells was not due to higher levels of baculovirus entry into the cells but, instead, arose through increased activity of the promoter.
We present here a relatively complete picture of baculovirus-induced antiviral immunity in mammalian cells. Because a pathogenic virus can evade its natural host's defense mechanism for successful infection, it is difficult to observe and examine uninterrupted host immune responses. However, because baculovirus is not infectious to mammalian cells, it provides a unique opportunity to study host immune responses against nonadaptive invading viral agents. Our experiments also provide informative results that can considerably improve transgene expression using baculovirus as an efficient vector in mammalian cells. We performed high-throughput screening of a lentivirus-based shRNA library targeting innate immune-related genes to identify host proteins that restrict baculovirus transgene expression in an A549 lung carcinoma cell line. We screened a total of 880 shRNA lentivirus clones targeting 176 genes chosen from the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database and specifically involved in the four major antiviral innate immune pathways (TLRs, RLRs, NLRs, and cytosolic DNA-sensing) to knock down their transcripts by an RNAi mechanism. Some of the genes were found to be involved in more than one immune signaling pathway. Each gene was targeted at five different regions by transduction with individual shRNA lentivirus clones. A schematic of our high-throughput screening methodology is illustrated in Figure 1 .
RESULTS

Screening
The cells were first transduced with individual shRNA lentivirus clones at an MOI of 10 for 24 hr, followed by transduction with recombinant baculovirus (vAcE) expressing a CMV promoter-driven EGFP 23 for 48 hr under puromycin for selection of cells harboring shRNA. The fluorescence intensity (FI) of EGFP-positive cells reflects the transgene expression level resulting from knockdown of the particular gene ( Figure 2 ; the pictures represent only a few genes). As a negative control, transduction of cells with a non-target shRNA sequence (shCtrl) was used throughout the experiment. FI was www.moleculartherapy.org averaged across the number of EGFP-positive cells in the particular wells and further normalized with the average FI obtained in the shCtrl well to obtain the relative fold changes in baculovirus transgene expression levels. Simultaneously, the effects of gene knockdown on cell viability were examined. The numbers of Hoechst dye-stained cells left after washing and fixing during the screening procedure were considered viable cells. To narrow down the genes of interest, we adopted stringent selection criteria. The EGFP expression level must be enhanced 2-fold compared with the negative control from at least three of five individual shRNA lentivirus clones targeted to the particular transcript, and at least one of the shRNA lentivirus clones must enhance gene expression by 5-fold or more. We found 43 candidates that met these criteria, but cell survival rates were variable (Table 1) . Baculovirus transgene expression was almost 10-fold greater under knockdown of five genes: IL-1b, TLR3, RIP1, CD14, and IKBKB. Of these five candidate genes, RIP1 knockdown did not have severe effects on cell viability (93%, clone e2; Figure 2 ). Considering that cell viability is a crucial factor in baculovirus transgene expression technology, we then focused on studying the biological role of RIP1 in baculovirus transgene expression.
Previously, it has been reported 18 that MEFs deficient for stimulator of IFN genes (STING), TANK binding kinase 1 (TBK1), IFN regulatory factor 3 (IRF3), or IFN-b promoter stimulator 1 (IPS-1) enhanced baculovirus transgene expression levels but not those deficient for IRF7, MyD88, or Z-DNA binding protein 1 (ZBP1)/DAI. Consistent with this observation, our screening results also showed that knockdown of TBK1, IRF3, and IPS-1/MAVS increased baculovirus transgene expression with different cell viability rates, but there was no significant effect in the case of IRF7 and MyD88 knockdown, indicating the reliability of our screening approach. The lentivirus shRNA clone targeting the STING gene was not available to us and so was excluded from our screening. Silencing of ZBP1 increased baculovirus transgene expression levels in our study, but with a reduced cell viability rate. We think that such discrepancies could be due to the different cell lines employed in the studies. Previous studies 18 and our results demonstrate that some antiviral innate immune genes potentially hamper baculovirus transgene expression.
Baculovirus Transduction Elevates RIP1 Expression Levels, and RIP1 Knockdown Enhances Baculovirus Transgene Expression without Affecting Viral Entry
Our RNAi screen identified RIP1 as a candidate gene that, upon silencing, greatly enhances baculovirus transgene expression without severe effects on cell viability. Transient knockdown of RIP1 by siRNA transfections also indicated a significant increase in baculovirus transgene expression ( Figure 3A) . To investigate the functional role of RIP1 in baculovirus transduction, we established A549 cell clones stably harboring shRNA for RIP1 (shRIP1) using puromycin selection. To validate our results, we transduced parental A549, A549-shCtrl, and A549-shRIP1 cells with vAcE at an MOI of 50 for 48 hr and recorded the EGFP expression levels. As observed in the screening process, transgene expression levels were higher in shRIP1 cells compared with those in shCtrl or parental cells ( Figure 3B ). Transgene expression levels were similar between parental and shCtrl cells, ruling out an effect of the lentiviruses and/or puromycin treatment under our experimental conditions. We performed RT-PCR analysis on RNA extracted from cells transduced with or without recombinant baculovirus (vAcE) to examine the knockdown efficiency of RIP1. Quantification of band intensities in the agarose gels showed that more than 90% of the RIP1 gene was successfully knocked down in shRIP1 cells. GAPDH gene amplification served as a cellular internal control ( Figure 3C ). qRT-PCR analysis revealed very low amounts of RIP1 mRNA expression in shRIP1 cells, corroborating the RT-PCR result. We also observed induction of RIP1 gene expression in parental and shCtrl cells as a function of time in response to baculovirus transduction ( Figure 3D ).
Next, we traced the RIP1 and EGFP protein levels in shCtrl or shRIP1 cells transduced with vAcE for various time points from 0-24 hr post-transduction (hpt) by western blotting. We found that RIP1 expression levels increased as early as 1 hpt and became more abundant as a function of time in the shCtrl cells but remained at low levels in shRIP1 cells, suggesting that baculovirus transduction modulates RIP1 protein expression in general. In contrast, EGFP protein derived from vAcE was significantly downregulated in shCtrl cells compared with shRIP1 cells, indicating that RIP1 protein inhibits baculovirus transgene expression. GAPDH protein served as an internal loading control in the western blot analyses ( Figure 4A ). We also observed increased RIP1 protein levels in shCtrl cells transduced either with recombinant vAcE or wild-type baculovirus (BV) compared with no baculovirus transduction at 18 hpt ( Figure 4B ).
In another set of experiments, we also observed that the mRNA expression level of EGFP, which was transduced into cells by vAcE, was significantly higher in shRIP1 cells compared with shCtrl cells ( Figure 4C ). To determine whether this baculovirus transgene enhancement was due to increased viral entry efficiency, we transduced shCtrl or shRIP1 cells with different concentrations of vAcE (MOI = 20 and 50) for 2 hr and then quantified the viral DNA by qPCR from the total cellular DNA. We did not observe statistical differences in the amount of viral DNA, suggesting that both shCtrl and shRIP1 cells were transduced with similar amounts of viral particles ( Figure 4D ). Overall, these results suggest that RIP1 does not affect viral entry but does restrict baculovirus transgene expression.
RIP1 Knockdown Elevates Dose-Dependent Baculovirus Transgene Expression in Mammalian Cells
It has been reported that baculovirus-mediated expression of reporter genes is relatively different among various mammalian cell lines. 10, 24 Therefore, to determine whether baculovirus transgene enhancement under RIP1 knockdown is A549 cell line-specific or could be applicable to other cell lines, we examined the baculovirus dose-dependent effect in U2OS (human osteosarcoma) and HEK293T cell lines. To this end, we first established shRIP1-stable or shCtrl-stable U2OS and HEK293T cell lines and then transduced them with different concentrations of vAcE for 48 hr. As shown in Figure 5 , the FI and the numbers of EGFP-positive cells increased according to viral dose in shRIP1 cells compared with shCtrl cells, with only minor differences among the cell lines tested. Apart from our visual observations, we quantified transgene expression levels by transducing cells with another recombinant baculovirus vAcL expressing CMV-promoterdriven firefly luciferase. Luciferase expression was significantly higher in shRIP1 cells compared with shCtrl cells in a dose-dependent fashion, and the expression pattern was similarly higher in A549 and U2OS cells compared with HEK293T-shRIP1 cells ( Figure 5B ). Maximum luciferase expression in shRIP1 cells was attained at MOI = 200 but dropped at a higher viral dose in both the A549 and U2OS cell lines. In contrast, HEK293T-shRIP1 cells showed gradual enhancement of luciferase expression with increasing the viral dose up to a maximum at MOI = 800 ( Figure 5 ). Transduction efficiencies varied among these cell lines, possibly because the culture conditions differed and the activation efficiencies of RIP1 between cell lines were different. These data suggest that RIP1 knockdown-mediated baculovirus transgene enhancement is not restricted to A549 cells but that the activation efficiency of various mammalian cell lines may be different. EGFP and luciferase expression was driven by the CMV promoter in the vAcE and vAcL viruses, respectively. We confirmed that our findings are not attributable to the CMV promoter alone because transduction of vAcmC (SV40 promoter-driven mCherry) and vAceE 25 (an EF-1a promoter with CMV enhancerdriven EGFP, kindly provided by Dr. Y. C. Hu) showed increased dose-dependent mCherry and EGFP expression in A549-shRIP1 compared with A549-shCtrl cells ( Figures S1 and S2 ).
Silencing of RIP1 Blocks Activation of TBK1/IRF3/IRF7/NF-kB Proteins in Baculovirus-Induced Immune Signaling
It has been well documented that RIP1 is involved in several signaling pathways ranging from TLRs, DNA damage sensors, and intracellular double-stranded RNA (dsRNA) sensors 15, 26, 27 and, furthermore, that baculovirus transduction induces the host innate immune responses through TLR-dependent and -independent signaling pathways. 16, 28 To understand the molecular mechanism of how RIP1 knockdown enhances baculovirus transgene expression, we examined the activation of RIP1 downstream proteins-TBK1/IRF3/IRF7/nuclear factor kB (NF-kB)-in response to baculovirus transduction. Upon stimulation, these proteins become phosphorylated, transmit a signal to downstream proteins, or translocate to the nucleus to induce the expression of cytokine or IFN genes 29, 30 that could affect baculovirus transgene expression. 17 To examine the activation of RIP1 downstream factors, we transduced A549-shRIP1 and A549-shCtrl cells with vAcE for various time points, and the cell lysates were subjected to western blotting with phospho-specific antibodies. None of the four TBK1/IRF3/ IRF7/NF-kB proteins in A549-shCtrl cells were activated up to 4 hpt, but they were strongly activated at 12 hpt and 18 hpt in response to baculovirus transduction ( Figure 6A ). Activation diminished to some extent at 24 hpt in the case of TBK1/IRF7/NF-kB proteins, but IRF3 remained active up to 24 hpt. In contrast, activation of these four proteins in A549-shRIP1 cells was almost abolished up to 24 hpt ( Figure 6A ). To test the inhibition of nuclear translocation of the phosphorylated transcription factors (IRF3/NF-kB) in shRIP1 cells, we performed an immunofluorescence assay of A549-shCtrl and A549-shRIP1 cells transduced with or without baculovirus (vAcE). Nuclear translocations of IRF3 and NF-kB proteins were clearly observed in A549-shCtrl cells, but, in contrast, nuclear translocation was significantly impeded in A549-shRIP1 cells, as in the case of A549-shCtrl cells transduced with baculovirus ( Figure 6B ). Furthermore, we also found that expression of IL-6 and IFN-b genes (downstream genes of NF-kB and IRF3) was dramatically downregulated in A549-shRIP1 compared with A549-shCtrl cells transduced with baculovirus ( Figure 6C ). These results indicate that RIP1 is an essential mediator of baculovirus-induced immune responses through the TBK1/IRF3/IRF7/NF-kB proteins. processes. 31 We examined the effect of Nec-1 on RIP1-mediated baculovirus transgene inhibition. Nec-1 was added to A549-shCtrl and A549-shRIP1 cells at various concentrations, and, 24 hr later, cells were transduced with vAcL (MOI = 50) for 48 hr. As shown in Figure 7A , luciferase activities increased greatly, reaching a maximum at 100 mM, and then declined with further dosages of Nec-1 in A549-shRIP1 cells, whereas a milder effect was observed for A549-shCtrl cells compared with untreated controls (0 mM). This result suggests that inhibiting the function of residual RIP1 by Nec-1 in RIP1 knockdown cells enhances baculovirus transgene expression. Next, we examined the effect of sodium butyrate (NaBu, a histone deacetylase inhibitor), which is commonly used to enhance baculovirus transgene expression under similar experimental conditions. 32 Compared with the untreated control (0 mM), NaBu (5 mM) had a significant effect on luciferase activity in RIP1 knockdown cells, but its effect gradually declined with increasing dosages. We did not observe significant transgene activation at a lower concentration of NaBu (2.5 mM) ( Figure S3 ) in A549 cells. NaBu is more effective than Nec-1 in stimulating baculovirus-mediated gene expression, but Nec-1 is strikingly more potent than NaBu in RIP1 knockdown cells, yielding a significant enhancement in baculovirus-mediated luciferase activity ( Figure 7B ). These results indicate that Nec-1 treatment promotes baculovirus transgene expression in RIP1 knockdown cells and imply that this strategy could be very useful in enhancing baculovirus-mediated transgene expression in mammalian cells. Our data suggest that baculovirus-induced immune responses attenuate transgene expression. In line with our findings, a recent report 18 also demonstrated that immune responses triggered by baculovirus are responsible for baculovirus transgene inhibition in MEFs. We wondered whether inhibition of baculovirus-mediated foreign gene expression is triggered by baculovirus transduction or due to the introduction of foreign recombinant DNA carried by the infecting baculovirus. To answer this question, we first used recombinant plasmid DNA carrying the EGFP gene under a CMV promoter (pABcE) to transfect A549-shCtrl and A549-shRIP1 cells. 5 hpt, cells were transduced with or without wild-type baculovirus. After incubation for a further 24 hr, EGFP fluorescence was assayed, and we found it to be significantly reduced in A549-shCtrl cells transduced with wildtype baculovirus compared with mock transduction. In contrast, no significant differences in EGFP fluorescence were observed in A549-shRIP1 cells transduced with or without baculovirus, suggesting that RIP1 was not induced by plasmid transfection to restrict foreign gene expression ( Figure 8A ). We also confirmed this finding with another recombinant plasmid DNA (pABcL) carrying the firefly luciferase gene. After transfection of A549-shCtrl and A549-shRIP1 cells with plasmid pABcL, we observed similar luciferase activity in these two cells without baculovirus transduction. However, luciferase activity was significantly reduced in A549-shCtrl cells, but not in A549-shRIP1 cells, upon baculovirus transduction ( Figure 8B ).
Collectively, these results demonstrate that RIP1 was induced by baculovirus transduction, but not by plasmid transfection, to restrict foreign gene expression.
In summary (Figure 9 ), our findings reveal that knockdown of RIP1, a common mediator upstream of TBK1 in TLR-, RIG-I-, and cytosolic DNA-sensing receptor signaling pathways, 26 affected in general or even inhibited by host immune responses. To improve baculovirus-mediated transgene expression, comprehensive screening of host immune responses and study of the mechanisms governing these restrictions are crucial, not only to improve gene expression but also to provide novel insights into the interactions between viruses and non-host cells. In this study, we used a comprehensive lentivirus-based shRNA library to search for most (if not all) genes that are specific for innate immune response sensors, adaptors, and early downstream signaling involved in four antiviral pathways. We identified numerous genes from these signaling pathways that negatively regulate baculovirus transgene expression. Among the silenced genes, RIP1, a common mediator in three antiviral pathways (TLR, RIG-I, and cytosolic DNA sensing), was identified as a strong negative regulator of baculovirus transgene expression. Our data indicate that RIP1 knockdown greatly inhibits the baculovirus-induced immune response and, consequently, enhances transgene expression.
It has previously been demonstrated that virus-induced pro-inflammatory cytokines and type I IFNs may inhibit transgene expression while also inducing cytotoxicity in target cells and tissues. 36, 37 Recently, it was shown that TLR-and RIG-I-mediated signaling components are activated in response to baculovirus and that the triggered immune response hinders transgene expression. 17, 18 Knockdown of antiviral immune signaling mediators is believed to be beneficial for viral growth in a cell type-dependent and/or virus-specific manner. For example, silencing of IRF7 in Madin Darby canine kidney (MDCK) cells contributed to high-yield production of influenza virus, 22 but knockdown of IRF7 did not show any beneficial role for baculovirus transgene expression in our study or in MEF cells. 18 As expected, direct inhibition of NF-kB did not increase baculovirus transgene expression because NF-kB has been shown to be a major activator of the CMV promoter. 38 Furthermore, silencing of the NOD1 and NOD2 receptors and genes, such as ERBB2IP and SUGT1, which all function in the NOD signaling pathway, enhanced baculovirus transgene expression, suggesting that the NOD pathway could also be involved in baculovirus-mediated gene expression. Intriguingly, silencing of IL-1b and TLR3 enhanced baculovirus transgene expression better than RIP1 knockdown, but cell viability was greatly affected under IL-1b-and TLR3-silenced conditions. Our experiments show that several antiviral immune pathways can be activated in response to baculovirus. Therefore, blocking one particular pathway may not be a good strategy to achieve efficient transgene expression. We found that blocking a common mediator, such as RIP1, which functions in at least three signaling pathways, enhanced transgene expression more effectively without affecting cell viability. RIP1 is an important component of many immune signaling pathways. It regulates mitogen-activated protein kinase (MAPK) and NF-kB activation as well as cell death. The intermediate domain of RIP1 regulates cell fate between necroptosis and RIP1-kinase-dependent apoptosis. 35 In the absence of RIP1, TLR3-mediated signals activating NF-kB were abolished, suggesting that TLR3-induced NF-kB activation is dependent on RIP kinases. 26 We found that silencing of RIP1 not only enhanced baculovirus transgene expression in A549, U2OS, and HEK293T cells ( Figure 5 ) but also in Vero-E6 and Chinese hamster ovary (CHO) cells (data not shown), suggesting that it could be a potential restriction factor in many cell types. Cells deficient in antiviral immune genes would be expected to exhibit increased baculovirus transgene expression. Therefore, it is puzzling why our baculovirus-transduced HEK239T cells, which are deficient in cGAS/STING proteins, 39 showed lower transgene expression levels at lower MOIs ( Figure 5 ) compared with A549 and U2OS cells. Thus, we anticipate that other antiviral factor(s) in addition to RIP1 might potentially restrict baculovirus transgene expression in HEK293T cells.
RIP1 knockdown led to inhibition of phosphorylation levels and nuclear translocation of downstream proteins (IRF3 and NF-kB) in signaling pathways, consequently reducing the expression of effector genes such as IFN-b and IL-6. Our observations are consistent with earlier studies showing the antiviral role of RIP1 in viral infections. In more recent studies, RIP1 has been found to associate with RIG-I in the presence of dsRNA and also play an important role in the type I IFN pathway. 29 Murine cytomegalovirus M45 protein inhibits NF-kB and P38 MAPK activation through RIP1 interaction to block pro-inflammatory and innate immune signaling pathways. 33, 34 Another report has also shown that the Tax protein of human T cell lymphotropic virus (HTLV) disrupts IRF7 function by binding to RIP1 and TRIF to escape from cellular host defense responses. 29 It has been well documented that, upon induction by viral infections, the host immune response inhibits transgene expression. [40] [41] [42] Baculovirus DNA may stimulate TLR3, RIG-I, and STING during transduction. 43, 44 In our study, RIP1 knockdown may have blocked TLR3 signaling and also influenced the translocation of NF-kB and IRF3/7 into the nucleus (Figure 6 ), which, in turn, decreased the expression of IL16 and IFN-b and resulted in suppression of the intrinsic innate immune response. Previous studies have also shown that viral DNA can stimulate the type I IFN and NF-kB-dependent pathways. 43, 44 Our results further show that, as well as playing a role in this mechanism, RIP1 may also affect RIG-I and STING signaling. www.moleculartherapy.org Similar to adeno-associated virus 40 and herpes simplex virus (HSV-1) 43 ,44 viral vectors, our study and an earlier report 18 reveal that baculovirus also induces type I IFN and multiple cytokines. IFNs released from infected host cells, in turn, activate IFN receptor (IFNR) and downstream STAT1 transcription factors to induce expression of antiviral genes. It has been demonstrated that type I IFN/STAT1 signaling is critical for transcriptional silencing of HSV viral amplicon-encoded transgenes both in vivo and in vitro. 44 Some reports have also shown that type 1 IFN signaling leads to activation of promyelocytic leukemia (PML) gene expression and the formation of PML nuclear bodies (PML-NBs, also known as ND10). PML-NBs have been shown to associate with viral DNA of simian virus 40, HSV, and cytomegalovirus in nuclei and to recruit the histone acetylase (HDAC) complex to silence viral gene expression during natural infection by these viruses. 45, 46 In our previous studies, we found that the baculovirus transactivator IE2 associates with PML protein in the NBs of baculovirustransduced mammalian cells. 47, 48 . Taken together, these observations lead us to speculate that low amounts of IFN and cytokines in baculovirus-transduced RIP1 knockdown cells may reduce PML-NB formation, resulting in enhancement of baculovirus transgene expression.
In summary, by using a high-throughput methodology to screen high numbers of host immune defense genes, we identified a series of target genes that function as negative regulators against baculovirus transgene expression. We found that RIP1 is one of the most significant factors inhibiting baculovirus transgene expression without resulting in extensive cell death. We also compared the ef- fects of a RIP1-specific inhibitor (Nec-1) 49 with a commonly used HDAC inhibitor (NaBu) on the enhancement of baculovirus transgene expression. Interestingly, Nec-1 significantly boosted baculovirus-mediated transgene expression in RIP1-silenced cells and was much more potent in its effects than NaBu. Gene expression of IFNs and cytokines can be downregulated by RIP1 silencing, and we found that RIP1 knockdown enhanced baculovirus transgene expression but did not affect viral entry into mammalian cells. Furthermore, we also discovered an intriguing phenomenon in that baculovirus transduction, but not recombinant DNA plasmid transfection, triggered host responses and, in turn, inhibited foreign gene expression. Overall, our study has not only analyzed virushost interactions through host immune-responsive genes, but it has also elucidated that the combination of RIP1 silencing plus Nec-1 treatment could be a very useful system to stimulate highlevel baculovirus transgene expression in many mammalian cells.
MATERIALS AND METHODS
Cells and Viruses
Insect cells (Sf21) were grown at 26 C in TC100 insect medium containing 10% (v/v) fetal bovine serum (FBS) (Gibco). A549 cells were grown in Ham's F12K medium (Gibco), U2OS cells were grown in McCoy's medium (Gibco), and 293T cells were grow in DMEM (Gibco). Each medium was supplemented with 100 U/mL penicillin, 100 mg/mL streptomycin, and 10% (v/v) FBS at 37 C in an air/CO 2 (19:1) incubator. vAcE, vAcL, vAc-mC, and vAceE are recombinant baculoviruses expressing GFP, luciferase, mCherry, and EGFP, respectively, by the CMV, SV40, and CMV-enhancer/EF-1a promoters. 23, 25 Briefly, the EGFP coding region was amplified by PCR from pEGFP-C1 and inserted into pTriEx-3 (Novagen) to generate pAcE. The luciferase coding region was amplified by PCR from pTRE-luc and inserted into pTriEx-3 to generate pAcL. Both EGFP and luciferase were driven by the CMV immediate-early enhancer and promoters. PCR-amplified mCherry was inserted into pTriEx-3 under the control of the SV40 promoter to generate pAcmC. The pAcE, pAcL, and pAcmC plasmids were co-transfected with a linearized viral DNA of AcMNPV (vAcRP23.Laz, Pharmingen) into Sf21 cells using Cellfectin (Life Technologies). The resulting recombinant baculoviruses (vAcE, vAcL, and vAcmC) were isolated through endpoint dilutions. Forty-eight hours after addition of virus, transduced cells were selected for stable clones by adding 2 mg/mL puromycin to growth medium for 2 weeks, and then surviving cells were collected for further applications.
RNA Extraction and qRT-PCR Analysis
Total RNA and total cellular DNA were extracted at various time points with TRIzol reagent (Invitrogen) and a DNeasy blood and tissue kit. Total RNA was extracted from A549 cells using RNAmini (QIAGEN) and reverse-transcribed using SuperScript III (Life Technologies). The quantity and quality of RNA were checked using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific). The amounts of each transcript were measured by qPCR using specific primers (Table 2) .
Genomic DNA Extraction and qPCR Analysis A549 cells were incubated with vAcE baculovirus for 2 hr and then washed with PBS three times and PBS with 0.1% trypsin once to remove free virus particles from cells. For viral entry efficiency, the total cellular DNA was extracted by a High Pure PCR Template Preparation Kit (Roche), and viral DNA copy number was determined by qPCR using gp41-specific primers 50 (Table 2) .
Western Blotting
Stable RIP1 knockdown clones of A549 cells (4 Â 10 5 ) in a 60-mm dish were transduced with vAcE baculovirus at an MOI of 50 for various www.moleculartherapy.org times as indicated. Cells were washed with ice-cold PBS and suspended in 0.2 mL lysis buffer (89901, Thermo Fisher Scientific) containing a protease inhibitor cocktail (B14001, Biotool). Cell lysates were sonicated (XL-2020, Misonix) and quantified by Bradford assay (23236, Thermo Fisher Scientific). Proteins (25 mg) were subjected to SDS-PAGE and transferred to nitrocellulose (NC) membranes (NBA085-C001EA, PerkinElmer). After washing, the membranes were blocked with 5% skim milk in Tris-Tween buffer saline (TTBS) and incubated with primary antibodies (1:1,000 dilution) at 4 C overnight. The primary antibodies were specific for RIP1 (610459, BD Transduction Laboratories), phospho (Ser536) in nuclear factor kappa-lightchain-enhancer of activated B cells (pNF-kB; Ser 536 ) (3033, Cell Signaling Technology), IRF3 (ab50772, Abcam), IRF7 (ab62505, Abcam), or GAPDH (GTX100118, GeneTex). After washing, the membranes were incubated with goat anti-mouse (115-035-003, Jackson ImmunoResearch) (for RIP1 and IRF3) or goat anti-rabbit (111-035-003, Jackson ImmunoResearch) (for pNF-kB and IRF7) secondary antibodies (1:5,000 dilution) conjugated with peroxidase at room temperature for 1 hr. The immune complexes were visualized with a Western Bright enhanced chemiluminescence (ECL) kit (K12045-D50, Advansta) and detected by X-ray films.
Immunofluorescence Assay
Eight-well Lab-Tek II chamber slides (Nunc) were seeded with RIP1 knockdown stable clones of A549 cells (4 Â 10 4 /well), and the cells were transduced with vAcE baculovirus at an MOI of 50 for various times as indicated. 24 hpt, the cells were washed three times with Dulbecco's PBS (DPBS; Invitrogen) and fixed with 4% paraformaldehyde for 10 min. Cells were washed three times with DPBS buffer and then permeabilized by incubation with À20 C 100% acetone for 10 min. After three 5-min washes in DPBS, the cells on the slides were blocked with blocking buffer (10% FBS in DPBS) for 1 hr and then incubated with the appropriate primary antibodies 
Cell Viability Assay
To determine relative cell metabolic activity, 10% v/v AlamarBlue was added to the cells and incubated for 1 hr. Reductions in AlamarBlue concentrations were measured with a fluorescence reader (EnSpire, PerkinElmer) at an excitation wavelength of 560 nm and an emission wavelength of 590 nm.
Plasmid Transfection
Transfections were performed using Lipofectamine 2000 reagent (Invitrogen). 1 Â 10 4 A549 cells were plated onto individual wells of a 24-well plate. A549 cells were transfected with 1000 ng of the reporter plasmid with the gfp gene driven by the CMV promoter. The transfection reagent was replaced by F12K medium after 5 hr.
Luciferase Assay
Cells were washed twice with PBS and lysed by 100 mL cell culture lysis reagent (CCLR; 100 mM potassium phosphate [pH 7.8], 0.2% Triton X-100, and 2 mM b-mercaptoethanol). Cell lysates were centrifuged at 3,500 rpm for 30 min at 4 C, and 20 mL supernatant was mixed with 180 mL luciferase assay reagent (LAR; 25 mM phosphate buffer [pH 7.8], 4 mM EGTA, 15 mM MgSO 4 , 1 mM dithiothreitol, and 0.2 mM ATP) in a black 96-well microplate. The samples in each well were injected with 0.2 mM luciferin (Promega). Luciferase activity was measured by a luminometer (EnSpire, PerkinElmer) for each well. Afterward, the results were plotted as average luciferase activities from triplicate assays of three independent experiments.
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